Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher
Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
HGH
1.15%
88.0¢
HEARTLAND GROUP HOLDINGS LIMITED - Announcements
Market Cap $865.4M
!
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
HGH | Heartland considers an institutional and retail note offer | PRICE SENSITIVE | 25/03/19 | |
HGH | HGH NZX Corporate Action Notice - 2019 Interim Dividend | PRICE SENSITIVE | 19/02/19 | |
HGH | Half Yearly Report and Accounts | PRICE SENSITIVE | 19/02/19 | |
HGH | Half Yearly Report and Accounts | PRICE SENSITIVE | 19/02/19 | |
HGH | Half Yearly Report and Accounts | PRICE SENSITIVE | 19/02/19 | |
HGH | Half Yearly Report and Accounts | PRICE SENSITIVE | 19/02/19 | |
HGH | Heartland Investor Day Presentation | PRICE SENSITIVE | 19/11/18 | |
HGH | First Quarter Results for Heartland Bank | PRICE SENSITIVE | 19/11/18 | |
HGH Heartland considers an institutional and retail note offer | |||
25/03/19 | PRICE SENSITIVE | ||
HGH HGH NZX Corporate Action Notice - 2019 Interim Dividend | |||
19/02/19 | PRICE SENSITIVE | ||
HGH Half Yearly Report and Accounts | |||
19/02/19 | PRICE SENSITIVE | ||
HGH Half Yearly Report and Accounts | |||
19/02/19 | PRICE SENSITIVE | ||
HGH Half Yearly Report and Accounts | |||
19/02/19 | PRICE SENSITIVE | ||
HGH Half Yearly Report and Accounts | |||
19/02/19 | PRICE SENSITIVE | ||
HGH Heartland Investor Day Presentation | |||
19/11/18 | PRICE SENSITIVE | ||
HGH First Quarter Results for Heartland Bank | |||
19/11/18 | PRICE SENSITIVE | ||